Therapeutic strategies to remodel immunologically cold tumors

Bibliographic Details
Title: Therapeutic strategies to remodel immunologically cold tumors
Authors: Minyu Wang, Sen Wang, Jayesh Desai, Joseph A Trapani, Paul J Neeson
Source: Clinical & Translational Immunology, Vol 9, Iss 12, Pp n/a-n/a (2020)
Publisher Information: Wiley, 2020.
Publication Year: 2020
Collection: LCC:Immunologic diseases. Allergy
Subject Terms: immune checkpoint inhibitor, tumor microenvironment, immune surveillance and resistance, cold tumor, therapeutic strategy, cancer immunotherapy, Immunologic diseases. Allergy, RC581-607
More Details: Abstract Immune checkpoint inhibitors (ICIs) induce a durable response in a wide range of tumor types, but only a minority of patients outside these ‘responsive’ tumor types respond, with some totally resistant. The primary predictor of intrinsic immune resistance to ICIs is the complete or near‐complete absence of lymphocytes from the tumor, so‐called immunologically cold tumors. Here, we propose two broad approaches to convert ‘cold’ tumors into ‘hot’ tumors. The first is to induce immunogenic tumor cell death, through the use of oncolytic viruses or bacteria, conventional cancer therapies (e.g. chemotherapy or radiation therapy) or small molecule drugs. The second approach is to target the tumor microenvironment, and covers diverse options such as depleting immune suppressive cells; inhibiting transforming growth factor‐beta; remodelling the tumor vasculature or hypoxic environment; strengthening the infiltration and activation of antigen‐presenting cells and/or effector T cells in the tumor microenvironment with immune modulators; and enhancing immunogenicity through personalised cancer vaccines. Strategies that successfully modify cold tumors to overcome their resistance to ICIs represent mechanistically driven approaches that will ultimately result in rational combination therapies to extend the clinical benefits of immunotherapy to a broader cancer cohort.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2050-0068
Relation: https://doaj.org/toc/2050-0068
DOI: 10.1002/cti2.1226
Access URL: https://doaj.org/article/2dea8cbb86c348f8bf8ac816c4d45a10
Accession Number: edsdoj.2dea8cbb86c348f8bf8ac816c4d45a10
Database: Directory of Open Access Journals
More Details
ISSN:20500068
DOI:10.1002/cti2.1226
Published in:Clinical & Translational Immunology
Language:English